Literature DB >> 1721361

FK 506 in clinical kidney transplantation.

R Shapiro1, M Jordan, V Scantlebury, J Fung, C Jensen, A Tzakis, J McCauley, P Carroll, C Ricordi, A J Demetris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721361      PMCID： PMC3035844     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

3.  The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.

Authors:  J P Boudreaux; L McHugh; D M Canafax; N Ascher; D E Sutherland; W Payne; R L Simmons; J S Najarian; D S Fryd
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939
  3 in total
  32 in total

1.  Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies.

Authors:  G Morris-Stiff; A Khan; I Quiroga; R Baboo; W A Jurewicz
Journal:  BMJ       Date:  1999-10-23

Review 2.  Immunosuppressive drugs in renal transplantation. A review of the regimens.

Authors:  J M Barry
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

3.  Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.

Authors:  A C Tsamandas; S M Pham; E C Seaberg; O Pappo; R L Kormos; A Kawai; B P Griffith; A Zeevi; R Duquesnoy; J J Fung; T E Starzl; A J Demetris
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

Review 4.  Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

Authors:  Angela C Webster; Rebecca C Woodroffe; Rod S Taylor; Jeremy R Chapman; Jonathan C Craig
Journal:  BMJ       Date:  2005-09-12

5.  Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.

Authors:  O Odocha; J McCauley; V Scantlebury; R Shapiro; P Carroll; M Jordan; C Vivas; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

6.  Fluconazole therapy in transplant recipients receiving FK506.

Authors:  R Mañez; M Martin; D Raman; D Silverman; A Jain; V Warty; I Gonzalez-Pinto; S Kusne; T E Starzl
Journal:  Transplantation       Date:  1994-05-27       Impact factor: 4.939

7.  Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; J J Fung; C Jensen; C Vivas; J McCauley; W D Irish; S Mitchell; A J Demetris
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

8.  Tacrolimus in renal transplantation.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; J McCauley; D Ellis; N Gilboa; S Lombardozzi-Lane; P Randhawa; A J Demetris; W Irish; T R Hakala; R L Simmons; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1996-08       Impact factor: 1.066

Review 9.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

10.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.